[1]
S. Madan, S. Kumar, and J. Segal, “Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants”, Acta Derm Venereol, vol. 100, no. 4, pp. 1–7, Feb. 2020.